奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603229 奥翔药业

已收盘 05-17 15:00:00

{"stockData":{"symbol":"603229","market":"SH","secType":"STK","nameCN":"奥翔药业","latestPrice":11.71,"timestamp":1715929200000,"preClose":11.67,"halted":0,"volume":4815735,"delay":0,"floatShares":593000000,"shares":593000000,"eps":0.4599,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"05-17 15:00:00","open":11.7,"high":11.77,"low":11.58,"amount":56135700,"amplitude":0.0163,"askPrice":11.71,"askSize":94,"bidPrice":11.69,"bidSize":383,"shortable":0,"etf":0,"ttmEps":0.4599,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":11.67,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":12.84,"lowLimit":10.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":593069389,"pbRate":3.07,"roa":"--","roe":"5.12%","epsLYR":0.43,"committee":0.473949,"marketValue":6945000000,"floatMarketCap":6945000000,"peRate":25.462057,"changeRate":0.0034,"turnoverRate":0.0081,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-20。"},"requestUrl":"/m/hq/s/603229","defaultTab":"news","newsList":[{"id":"2436133923","title":"奥翔药业公布国际专利申请：“芦可替尼晶体及其药物组合物”","url":"https://stock-news.laohu8.com/highlight/detail?id=2436133923","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436133923?lang=zh_cn&edition=full","pubTime":"2024-05-18 04:28","pubTimestamp":1715977700,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示奥翔药业公布了一项国际专利申请，专利名为“芦可替尼晶体及其药物组合物”，专利申请号为PCT/CN2023/130777，国际公布日为2024年5月16日。专利详情如下：图片来源：世界知识产权组织今年以来奥翔药业已公布的国际专利申请1个，较去年同期减少了50%。结合公司2023年年报财务数据，2023年公司在研发方面投入了7805.79万元，同比增16.38%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051800004595.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2436629939","title":"奥翔药业05月17日遭主力抛售593万元 环比增加177.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436629939","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436629939?lang=zh_cn&edition=full","pubTime":"2024-05-17 15:18","pubTimestamp":1715930334,"startTime":"0","endTime":"0","summary":"05月17日, 奥翔药业股价涨0.34%，报收11.71元，成交金额5613万元，换手率0.81%，振幅1.63%，量比0.84。奥翔药业今日主力资金净流出593万元，上一交易日主力净流出214万元，今日环比增加177.10%。该股近5个交易日下跌0.76%，主力资金累计净流出789万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2761万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171531388b11a877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171531388b11a877&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435168646","title":"主业稳健发展，努力打造第三增长曲线！奥翔药业有望“展翅翱翔”","url":"https://stock-news.laohu8.com/highlight/detail?id=2435168646","media":"览富财经网","top":-1,"share":"https://www.laohu8.com/m/news/2435168646?lang=zh_cn&edition=full","pubTime":"2024-05-15 16:00","pubTimestamp":1715760002,"startTime":"0","endTime":"0","summary":"不断夯实主业发展，同时积极拓展其他业务，奥翔药业未来有望“展翅翱翔”。主业稳健发展，业绩逐年提升奥翔药业是一家从事药物制剂、特色原料药、医药关键中间体的研发生产和销售的高新技术企业。得益于原料药及中间体业务的持续增长，奥翔药业的经营业绩也稳步提升。截至2023 年末，奥翔药业共有在研项目43个，其中已申报项目6项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151605528b0a7794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151605528b0a7794&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434054026","title":"奥翔药业05月09日主力资金流出184万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2434054026","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434054026?lang=zh_cn&edition=full","pubTime":"2024-05-09 15:18","pubTimestamp":1715239091,"startTime":"0","endTime":"0","summary":"05月09日, 奥翔药业股价涨0.42%，报收11.93元，成交金额7364万元，换手率1.04%，振幅2.86%，量比0.53。奥翔药业今日主力资金净流出184万元，连续3日净流出，上一交易日主力净流出1154万元，今日环比减少84.06%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为56.00%，平均跌幅为1.58%。该股近5个交易日上涨5.20%，主力资金累计净流出933万元；近20日主力资金累计净流出2152万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050915264687e3919a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050915264687e3919a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展：谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三，谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型，能够帮助科学家更精确地针对疾病机制，从而开发出更有效的治疗药物。据太平洋证券医药，AI制药内涵丰富，主要包括：数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433716394","title":"奥翔药业05月08日遭主力抛售1154万元 环比增加186.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433716394","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433716394?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:18","pubTimestamp":1715152715,"startTime":"0","endTime":"0","summary":"05月08日, 奥翔药业股价跌0.92%，报收11.88元，成交金额9653万元，换手率1.37%，振幅3.17%，量比0.75。奥翔药业今日主力资金净流出1154万元，上一交易日主力净流出403万元，今日环比增加186.35%。|05月08日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|*ST宁科|4.87%|#|新朋股份|3.95%|#|鲁抗医药|3.88%|#|*ST傲农|3.69%|#|瑞丰高材|3.55%|#|福日电子|3.28%|#|香雪制药|3.24%|#|恒大高新|3.20%|#|广康生化|3.16%|#|开能健康|3.14%|奥翔药业所在的化学制药行业，今日主力净流入4.07亿元，行业排名4/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081531228ae7d68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081531228ae7d68c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433403261","title":"北向资金5月6日净买入奥翔药业1.03万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2433403261","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433403261?lang=zh_cn&edition=full","pubTime":"2024-05-07 09:30","pubTimestamp":1715045429,"startTime":"0","endTime":"0","summary":"5月6日, 北向资金增持奥翔药业1.03万股，连续5日增持。截止当日收盘，沪股通共持有奥翔药业598.74万股，占流通股1.00%。沪股通增持金额前五个股分别为贵州茅台、招商银行、中国平安、紫金矿业、三一重工。奥翔药业近5个交易日上涨17.05%，沪股通累计增持171.12万股；近20个交易日上涨11.94%，沪股通累计增持55.20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050709343587da5e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050709343587da5e44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433412510","title":"奥翔药业05月06日主力资金流入320万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2433412510","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433412510?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:19","pubTimestamp":1714979944,"startTime":"0","endTime":"0","summary":"05月06日, 奥翔药业股价涨1.72%，报收11.81元，成交金额1.43亿元，换手率2.07%，振幅3.36%，量比1.53。奥翔药业今日主力资金净流入320万元，连续3日净流入，上一交易日主力净流入486万元，今日环比减少34.16%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为25.00%，平均涨幅为3.84%。该股近5个交易日上涨17.05%，主力资金累计净流入691万元；近20日主力资金累计净流出719万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050615344487d78e0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050615344487d78e0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431634246","title":"奥翔药业：\n目前尚未进入到三期,相关工作按计划推进，公司会严格按照相关法律法规要求做好信息披露工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2431634246","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431634246?lang=zh_cn&edition=full","pubTime":"2024-04-30 20:50","pubTimestamp":1714481434,"startTime":"0","endTime":"0","summary":"证券之星消息，奥翔药业(603229)04月30日在投资者关系平台上答复投资者关心的问题。投资者：布罗佐喷钠，22年报披露就是已完成2期临床，待进入三期，23年报进度还是一样。请问为何没有进展？还有多久能进入三期，一般三期临床持续时间多久？奥翔药业董秘：投资者您好：目前尚未进入到三期,相关工作按计划推进，公司会严格按照相关法律法规要求做好信息披露工作。感谢您对公司的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000049897.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431009838","title":"北向资金4月29日净买入奥翔药业125.10万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2431009838","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431009838?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:30","pubTimestamp":1714440627,"startTime":"0","endTime":"0","summary":"4月29日, 北向资金增持奥翔药业125.10万股，连续3日增持。截止当日收盘，沪股通共持有奥翔药业570.39万股，占流通股0.96%。沪股通增持金额前五个股分别为江苏银行、陕西煤业、宇通客车、三一重工、韦尔股份。奥翔药业近5个交易日上涨14.20%，沪股通累计增持149.63万股；近20个交易日上涨11.18%，沪股通累计增持68.57万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300935288b642966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300935288b642966&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431808976","title":"奥翔药业获融资买入0.12亿元，近三日累计买入0.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431808976","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431808976?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:25","pubTimestamp":1714436713,"startTime":"0","endTime":"0","summary":"4月29日，沪深两融数据显示，奥翔药业获融资买入额0.12亿元，居两市第831位，当日融资偿还额0.12亿元，净卖出12.94万元。最近三个交易日，25日-29日，奥翔药业分别获融资买入0.03亿元、0.02亿元、0.12亿元。融券方面，当日融券卖出5.45万股，净卖出4.81万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043008265787c159a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043008265787c159a5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431743238","title":"奥翔药业（603229）4月29日主力资金净买入95.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431743238","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431743238?lang=zh_cn&edition=full","pubTime":"2024-04-30 07:42","pubTimestamp":1714434151,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月29日收盘，奥翔药业报收于11.34元，上涨8.1%，换手率2.73%，成交量16.21万手，成交额1.83亿元。近5日资金流向一览见下表：奥翔药业融资融券信息显示，融资方面，当日融资买入1191.98万元，融资偿还1204.92万元，融资净偿还12.94万元。奥翔药业主营业务：特色原料药及医药中间体的研发、生产和销售,以及为客户提供定制生产和研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000013572.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431883548","title":"奥翔药业涨8.10%，国金证券一日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431883548","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431883548?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:25","pubTimestamp":1714379152,"startTime":"0","endTime":"0","summary":"今日奥翔药业涨8.10%，收盘报11.34元。2024年4月28日，国金证券研究员袁维发布了对奥翔药业的研报《产能释放蓄力API增长》，该研报对奥翔药业给出“买入”评级。研报中预计公司2024-2026年归母净利润为3.12/3.97/4.91亿元，对应PE分别为20/16/13倍，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为65.16%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为浙商证券的孙建。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291634258b610eb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291634258b610eb8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431028762","title":"新冠药物概念盘中拉升，奥翔药业涨8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431028762","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431028762?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:26","pubTimestamp":1714357603,"startTime":"0","endTime":"0","summary":"04月29日，新冠药物概念盘中拉升，截至10点26分，新冠药物概念整体指数上涨2.01%，报508.430点。从个股上来看，该概念的成分股中，奥翔药业涨8.20%，科兴制药、之江生物等3只股涨幅超过5%。从资金上来看，截止发稿，新冠药物概念主力净流入为-1.70亿，其中众生药业受到资金热捧，主力净流入1070.90万；拉长时间线来看，该板块近20日主力资金净流入-32.59亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291026437924a8d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291026437924a8d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431857044","title":"肝炎概念盘中拉升，奥翔药业涨7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431857044","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431857044?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:38","pubTimestamp":1714354715,"startTime":"0","endTime":"0","summary":"04月29日，肝炎概念盘中拉升，截至09点38分，肝炎概念整体指数上涨1.02%，报830.350点。从个股上来看，该概念的成分股中，奥翔药业涨7.82%，之江生物、汉森制药2只股涨幅超过5%。从资金上来看，截止发稿，肝炎概念概念主力净流入为-4823.61万，其中浙江震元受到资金热捧，主力净流入472.83万；拉长时间线来看，该板块近20日主力资金净流入-29.16亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429093835861e9c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429093835861e9c46&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431041071","title":"奥翔药业上涨创1月新高 特色原料药项目产能建设完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2431041071","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2431041071?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:32","pubTimestamp":1714354348,"startTime":"0","endTime":"0","summary":"消息解读奥翔药业2024年第一季度营收约3.01亿元，同比增加14.61%；归属于上市公司股东的净利润约1.12亿元，同比增加20.08%。北向资金方面，奥翔药业04月26日获得北向资金增持2.60万股，截至04月26日，北向资金当前共持有奥翔药业445.29万股，市值4911万元，持股占流通股比为0.75%。主营业务及业绩奥翔药业公司主营业务为特色原料药及医药中间体的研发、生产和销售，以及为客户提供定制生产和研发业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290937467a56dd66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290937467a56dd66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430427768","title":"奥翔药业2023年营收8.17亿净利2.54亿 董事长郑志国薪酬112.16万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430427768","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430427768?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:25","pubTimestamp":1714137913,"startTime":"0","endTime":"0","summary":"挖贝网4月26日，奥翔药业 近日发布2023年年度报告，报告期内公司实现营业收入816,765,083.27元，同比增长6.83%；归属于上市公司股东的净利润253,901,967.43元，同比增长7.87%。报告期内经营活动产生的现金流量净额为221,847,783.71元，归属于上市公司股东的净资产2,141,576,554.10元。公告显示，报告期内董事、监事、高级管理人员报酬合计758.06万元。本次转增完成后，公司总股本将由593,069,389股增加至830,297,145股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621275787b3ecc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621275787b3ecc5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430276194","title":"奥翔药业：2024年第一季度净利润约1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430276194","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430276194?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:41","pubTimestamp":1714128117,"startTime":"0","endTime":"0","summary":"奥翔药业（SH 603229，收盘价：10.49元）4月26日晚间发布一季度业绩公告称，2024年第一季度营收约3.01亿元，同比增加14.61%；归属于上市公司股东的净利润约1.12亿元，同比增加20.08%；基本每股收益0.19元，同比增加18.75%。奥翔药业的董事长、总经理均是郑志国，男，53岁，学历背景为大专。截至发稿，奥翔药业市值为62亿元。文章来源：每日经济新闻原标题：奥翔药业：2024年第一季度净利润约1.12亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042619590987b38790&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042619590987b38790&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430224402","title":"奥翔药业最新公告：2023年净利润2.54亿元 同比增加7.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430224402","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430224402?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:40","pubTimestamp":1714128059,"startTime":"0","endTime":"0","summary":"奥翔药业发布2023年度业绩报告，报告期内公司实现营业收入8.17亿元，同比增加6.83%;归属于上市公司股东的净利润2.54亿元，同比增加7.87%;归属于上市公司股东的扣除非经常性损益的净利润2.43亿元，同比增加6.57%;基本每股收益0.43元，公司拟向全体股东每10股派发现金红利人民币1.29元(含税)，以资本公积金转增股本方式向全体股东按每10股转增4股。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600046301.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430244462","title":"奥翔药业最新公告：一季度净利润1.12亿元 同比增加20.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430244462","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430244462?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:39","pubTimestamp":1714127990,"startTime":"0","endTime":"0","summary":"奥翔药业发布2024年一季度报告，报告期内公司实现营业收入3.01亿元，同比增加14.61%;归属于上市公司股东的净利润1.12亿元，同比增加20.08%;归属于上市公司股东的扣除非经常性损益的净利润1.08亿元，同比增加17.69%;基本每股收益0.19元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600046317.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-05-09","address":"浙江省台州市临海市化学原料药基地临海园区东海第四大道5号","stockEarnings":[{"period":"1week","weight":-0.0076},{"period":"1month","weight":0.1745},{"period":"3month","weight":0.138},{"period":"6month","weight":-0.2224},{"period":"1year","weight":-0.2675},{"period":"ytd","weight":-0.1136}],"companyName":"浙江奥翔药业股份有限公司","boardCode":"AI0027","perCapita":"18834股","boardName":"医药制造业","registeredCapital":"59306万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　浙江奥翔药业股份有限公司主要从事特色原料药及医药中间体的研发、生产与销售，以及为客户提供定制生产和研发业务。公司的主要产品按治疗领域与产品用途主要分为九个大类，分别为肝病类、呼吸系统类、心脑血管类、高端氟产品类、前列腺素类、抗菌类、痛风类、抗肿瘤类和神经系统类。目前，公司的成熟产品已有双环醇、恩替卡韦、西他沙星、泊沙康唑、非布司他、奈必洛尔、米格列醇等。","serverTime":1716006876849,"listedPrice":7.81,"stockholders":"31488人(较上一季度减少2.58%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥翔药业,603229,奥翔药业股票,奥翔药业股票老虎,奥翔药业股票老虎国际,奥翔药业行情,奥翔药业股票行情,奥翔药业股价,奥翔药业股市,奥翔药业股票价格,奥翔药业股票交易,奥翔药业股票购买,奥翔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}